US Broker Ratings

TG Therapeutics, Inc. (TGTX) Stock Analysis: Potential 26.52% Upside Amid Robust Revenue Growth

TG Therapeutics, Inc. (NASDAQ: TGTX) is making waves in the biotechnology sector with its strong focus on developing innovative treatments for B-cell mediated diseases. As a commercial-stage biopharmaceutical company, TG..

Zoetis Inc. (ZTS) Stock Analysis: Unveiling a 60% Potential Upside in the Healthcare Sector

Zoetis Inc. (NYSE: ZTS), a prominent player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, is capturing investors’ attention with its promising 60.37% potential upside...

Masimo Corporation (MASI) Stock Analysis: Evaluating the Healthcare Innovator’s Performance and Growth Potential

Masimo Corporation (MASI), a key player in the healthcare sector’s medical devices industry, has long been at the forefront of patient monitoring technology. With a market capitalization of $9.35 billion,..

Solventum Corporation (SOLV) Stock Analysis: Strong Return on Equity and Investor Ratings Signal Potential Growth

Solventum Corporation (NASDAQ: SOLV), a key player in the healthcare sector with a focus on medical instruments and supplies, presents an intriguing opportunity for investors seeking a blend of innovation..

Elanco Animal Health (ELAN) Stock Analysis: 24.89% Potential Upside Beckons Investors

Elanco Animal Health Incorporated (NYSE: ELAN), a key player in the healthcare sector focusing on specialty and generic drug manufacturing, presents an intriguing opportunity for investors eyeing the animal health..

Guardant Health, Inc. (GH) Stock Analysis: Navigating the Rapid Growth in Precision Oncology

Guardant Health, Inc. (NASDAQ: GH), a frontrunner in the rapidly evolving field of precision oncology, continues to capture the attention of investors with its promising growth trajectory and innovative diagnostic..

Merit Medical Systems (MMSI) Stock Analysis: Exploring a 43.73% Upside Potential

Merit Medical Systems, Inc. (NASDAQ: MMSI), a key player in the healthcare sector, is emerging as a promising opportunity for investors seeking exposure to the Medical Instruments & Supplies industry...

TransMedics Group, Inc. (TMDX) Stock Analysis: A 73.78% Potential Upside in the Medical Devices Sector

TransMedics Group, Inc. (NASDAQ: TMDX) has emerged as a compelling player in the highly specialized field of organ transplant technology. This Andover, Massachusetts-based company is making waves in the medical..

ADMA Biologics Inc (ADMA) Stock Analysis: Exploring a 109.90% Potential Upside Amid Robust Revenue Growth

ADMA Biologics Inc (NASDAQ: ADMA), a prominent player in the biotechnology sector, is capturing investor attention due to its significant potential upside of 109.90%, as reflected in analyst price targets...

Integer Holdings Corporation (ITGR) Stock Analysis: Potential Upside and Strong Buy Ratings in the Medical Device Sector

Investors eyeing the healthcare sector might find Integer Holdings Corporation (NYSE: ITGR) an intriguing opportunity with its robust position in the medical device industry. With a market capitalization of $3.03..

Danaher Corporation (DHR) Stock Analysis: Exploring a 34% Potential Upside Amid Strong Buy Ratings

Danaher Corporation (NYSE: DHR), a stalwart in the healthcare sector, continues to capture the attention of investors with its solid performance and promising growth potential. Operating through its biotechnology, life..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Healthcare Giant with a 17.86% Upside Potential

Smith & Nephew SNATS, Inc. (NYSE: SNN) stands as a prominent player in the healthcare sector, specializing in medical devices. With a market capitalization of $12.62 billion, this UK-based company..

Royalty Pharma plc (RPRX) Stock Analysis: Evaluating Its 6.26% Potential Upside and Strong Buy Ratings

Royalty Pharma plc (NASDAQ: RPRX) stands out in the biotechnology sector, not just for its unique business model as a buyer of biopharmaceutical royalties but also for its robust market..

Cardinal Health, Inc. (CAH) Stock Analysis: Capitalizing on a 24.63% Potential Upside

Cardinal Health, Inc. (CAH) stands as a formidable player in the healthcare sector, specifically within the medical distribution industry. Headquartered in Dublin, Ohio, this Fortune 500 company operates globally, offering..

Alkermes plc (ALKS) Stock Analysis: Solid Growth Potential with 28.2% Revenue Surge and Analyst Consensus

Alkermes plc (NASDAQ: ALKS), a prominent player in the healthcare sector, operates within the specialty and generic drug manufacturing industry. Headquartered in Dublin, Ireland, Alkermes has carved a niche for..

Koninklijke Philips N.V. (PHG) Stock Analysis: Exploring a 27% Potential Upside for Investors

As Koninklijke Philips N.V. (NYSE: PHG), a stalwart in the healthcare sector, continues to navigate the challenging landscape of the medical devices industry, investors are keenly eyeing its growth potential..

Option Care Health, Inc. (OPCH) Stock Analysis: Unveiling a 39.83% Upside Potential

Option Care Health, Inc. (NASDAQ: OPCH) stands as a significant player in the healthcare sector, specializing in home and alternate site infusion services across the United States. With a market..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: A Biotech Powerhouse with Strong Buy Ratings and Growth Potential

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) stands as a formidable entity within the biotechnology industry, hailing from Ireland and making significant strides in healthcare innovation. With a robust market capitalization of..

Bristol-Myers Squibb (BMY) Stock Analysis: Navigating a 10.32% Potential Upside Amidst Healthcare Innovation

Bristol-Myers Squibb Company (NYSE: BMY), a titan in the global biopharmaceutical industry, is capturing investor attention with a potential 10.32% upside based on its current average target price. As a..

Novartis AG (NVS) Stock Analysis: Evaluating the 2.46% Upside Potential in a Dynamic Healthcare Market

Novartis AG (NYSE: NVS), a leading player in the global pharmaceutical industry, continues to capture investor interest with its robust portfolio and strategic growth initiatives. Headquartered in Basel, Switzerland, Novartis..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds